NDC 72934-2097

HYALURONIC ACID SODIUM SALT 1% / TACROLIMUS 0.1% / UREA 20%

Hyaluronic Acid Sodium Salt 1% / Tacrolimus 0.1% / Urea 20%

HYALURONIC ACID SODIUM SALT 1% / TACROLIMUS 0.1% / UREA 20% is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Urea; Hyaluronate Sodium; Tacrolimus.

• Product ID: 72934-2097_89036512-64f7-224b-e053-2a95a90a8068
• NDC: 72934-2097
• Product Type: Human Prescription Drug
• Proprietary Name: HYALURONIC ACID SODIUM SALT 1% / TACROLIMUS 0.1% / UREA 20%
• Generic Name: Hyaluronic Acid Sodium Salt 1% / Tacrolimus 0.1% / Urea 20%
• Dosage Form: Cream
• Route of Administration: TOPICAL
• Marketing Start Date: 2019-05-17
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: Sincerus Florida, LLC
• Substance Name: UREA; HYALURONATE SODIUM; TACROLIMUS
• Active Ingredient Strength: 20 g/100g; g/100g; g/100g
• Pharm Classes: Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 72934-2097-2

30 g in 1 BOTTLE, PUMP (72934-2097-2)

• Marketing Start Date: 2019-05-17
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 72934-2097-2 [72934209702]

HYALURONIC ACID SODIUM SALT 1% / TACROLIMUS 0.1% / UREA 20% CREAM

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2019-05-17

Drug Details

Active Ingredients

Ingredient	Strength
UREA	20 g/100g

OpenFDA Data

• SPL SET ID: 89036512-64f6-224b-e053-2a95a90a8068
• Manufacturer:
  • Sincerus Florida, LLC
• UNII:
  • YSE9PPT4TH
  • WM0HAQ4WNM
  • 8W8T17847W

Pharmacological Class

• Calcineurin Inhibitor Immunosuppressant [EPC]
• Calcineurin Inhibitors [MoA]
• Calcineurin Inhibitor Immunosuppressant [EPC]
• Calcineurin Inhibitors [MoA]